258 Atul Ltd | Annual Report 2022-23 Atul Ltd | Annual Report 2022-23 Atul Ltd Atul House G I Patel Marg Ahmedabad 380 014, Gujarat India Atul Ltd | Annual Report 2022-23 Reconnect | Reimagine | Regrow Corporate Overview Statutory Reports Financial Statements (` cr) Summarised Balance Sheet Amal Ltd As at March 31, 2023 As at March 31, 2022 Current assets 11.28 4.81 Current liabilities 7.16 9.04 Net current assets 4.12 (4.23) Non-current assets 105.60 63.77 Non-current liabilities 1.19 1.14 Net non-current assets 104.41 62.63 Net assets 108.53 58.40 Accumulated NCI 54.42 29.12 (` cr) Summarised Statement of Profit and Loss Amal Ltd 2022-23 2021-22 Revenue 43.19 45.30 Profit for the year 0.73 2.43 Other comprehensive income 0.03 (0.01) Total comprehensive income 0.76 2.41 Profit allocated to NCI 0.38 1.21 Dividends paid to NCI - - (` cr) Summarised cash flows Amal Ltd 2022-23 2021-22 Cash flows from operating activities (1.17) 4.91 Cash flows from investing activities (21.32) (3.77) Cash flows from financing activities 23.74 (1.22) Net increase | (decrease) in cash and cash equivalents 1.25 (0.08) c ) Interests in associate and joint venture company accounted for using the equity method (` cr) Name of the entity Place of business | country of incorporation % of ownership interest Relationship Quoted fair value Carrying amount As at March 31, 2023 As at March 31, 2022 As at March 31, 2023 As at March 31, 2022 Rudolf Atul Chemicals Ltd India 50% Joint venture * * 20.37 28.11 Valsad Institute of Medical Sciences Ltd India 50% Associate * * 22.39 - Total 42.76 28.11 *Note: Unlisted entity - no quoted price available Rudolf Atul Chemicals Ltd The Group acquired 50% interest in Rudolf Atul Chemicals Ltd (RACL), a joint venture company in India between IB Industriechemie Beteiligungs GmbH (Germany) and Atul Ltd on August 18, 2011. RACL is engaged in the business of manufacturing and marketing textile chemicals. As per the contractual arrangement between the shareholders of RACL, both the companies have significant participating rights such that they jointly control the operations of the joint venture company. Note 30.16 Interests in other entities (continued)
RkJQdWJsaXNoZXIy MjA2MDI2